Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Brusselle, Guy" or (type exact bookEditor and editor="Brusselle, Guy")

Add to list
- Journal Article
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-asthma Biologics’

Guy Brusselle (UGent)

(2024) J ALLERGY CLIN IMMUNOL PRACT.
Add to list
Anti-inflammatoire reliever (AIR) als eerstekeuzebehandeling bij mild astma : nieuwe aanbevelingen op basis van de 2023 ERS Task Force ICS/formoterol in mild astma

Sebastian Riemann (UGent) and Guy Brusselle (UGent)

(2024) BLOEDVATEN, HART, LONGEN. 29(1). p.30-34
Add to list
- Conference Paper
Research Day 2024: Impact of exogenous sex steroids in asthma: interim results of the ENIGI-lung study

Sebastian Riemann (UGent) , Jeroen Vervalcke (UGent) , Guy T'Sjoen (UGent) and Guy Brusselle (UGent)

(2024)
Add to list
- Journal Article
- A1
- open access
The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study

Tianqi Lu, Lies Lahousse (UGent) , Sara Wijnant, Jinluan Chen, Guy Brusselle (UGent) , Mandy van Hoek and M. Carola Zillikens

(2024) RESPIRATORY RESEARCH. 25(1).
Add to list
- Journal Article
- open access
Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA Delivery

Bram Bogaert (UGent) , Aliona Debisschop (UGent) , Thomas Ehouarne (UGent) , Hannelore Van Eeckhoutte (UGent) , Joyceline De Volder (UGent) , An Jacobs, Eline Pottie (UGent) , Riet De Rycke (UGent) , Aurélie Crabbé (UGent) , Pieter Mestdagh (UGent) , et al.

(2024) Nano Letters. 24(10). p.2961-2971
Add to list
- Journal Article
- A1
- open access
Flemish network on rare connective tissue diseases (CTD) : patient pathways in systemic sclerosis : first steps taken

Yves Piette (UGent) , Freek Van den Bossche (UGent) , J. Aerts, N. Aerts, S. Ajeganova, V. Badot, N. Berghen, D. Blockmans, Guy Brusselle (UGent) , N. Caeyers, et al.

(2024) ACTA CLINICA BELGICA. 79(1). p.26-33
Add to list
- Journal Article
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose

Guy Brusselle (UGent)

(2023) ERJ Open Research.
Add to list
- Journal Article
- A1
- open access
Reply to Lipworth and Chan

Sebastian Riemann (UGent) and Guy Brusselle (UGent)

(2023) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 208(2). p.211-212
Add to list
- Miscellaneous
- open access
Is efficacy of tezepelumab independent of severe asthma phenotype?

Guy Brusselle (UGent) and Sebastian Riemann (UGent)

(2023) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 208(1). p.1-3
Add to list
- Miscellaneous
Risk stratifying interstitial lung abnormalities to guide early diagnosis interstitial lung diseases

Marlies S Wijsenbeek and Guy Brusselle (UGent)

(2023) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In 207 1. p.9-11

Academic Bibliography

Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-asthma Biologics’

Anti-inflammatoire reliever (AIR) als eerstekeuzebehandeling bij mild astma : nieuwe aanbevelingen op basis van de 2023 ERS Task Force ICS/formoterol in mild astma

Research Day 2024: Impact of exogenous sex steroids in asthma: interim results of the ENIGI-lung study

The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study

Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA Delivery

Flemish network on rare connective tissue diseases (CTD) : patient pathways in systemic sclerosis : first steps taken

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose

Reply to Lipworth and Chan

Is efficacy of tezepelumab independent of severe asthma phenotype?

Risk stratifying interstitial lung abnormalities to guide early diagnosis interstitial lung diseases

Contents

Support

Contact